Figure 4

Overall survival according to AID expression. Patients with AID-negative lymphomas have a longer median survival than patients with AID-positive small lymphocytic lymphomas (130 vs 61 months).
Overall survival according to AID expression. Patients with AID-negative lymphomas have a longer median survival than patients with AID-positive small lymphocytic lymphomas (130 vs 61 months).